(Q73227469)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9104904%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Comparisons of oral propafenone and sotalol as an initial treatment in patients with symptomatic paroxysmal atrial fibrillation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9104904%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

S H Lee

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9104904%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

S A Chen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9104904%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

C T Tai

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9104904%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

C E Chiang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9104904%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Z C Wen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9104904%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Y J Chen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9104904%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

W C Yu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9104904%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J L Huang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9104904%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A N Fong

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9104904%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J J Cheng

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9104904%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M S Chang

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9104904%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

English

0 references

publication date

1 April 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9104904%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9104904%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9104904%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9104904%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

905-908

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9104904%20AND%20SRC:MED&resulttype=core&format=json

The multiple modes of action of propafenone

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900025-8

Propafenone for paroxysmal atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900025-8

Propafenone for prevention of recurrent atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900025-8

Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900025-8

Long-term oral propafenone therapy for suppression of refractory symptomatic atrial fibrillation and atrial flutter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900025-8

Comparisons of oral propafenone and quinidine as an initial treatment option in patients with symptomatic paroxysmal atrial fibrillation: a double-blind, randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900025-8

Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900025-8

Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900025-8

Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900025-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900025-8

Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900025-8

Cardiac arrhythmias and the autonomic nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900025-8

Clinical safety profile of sotalol in patients with arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900025-8

Transtelephonic electrocardiographic transmission for management of cardiac arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900025-8

Possible atrial proarrhythmic effects of class 1C antiarrhythmic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900025-8

Atrial flutter in patients treated for atrial fibrillation with propafenone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900025-8

The hazards of using type 1C antiarrhythmic drugs for the treatment of paroxysmal atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900025-8

10.1016/S0002-9149(97)00025-8

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9104904%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference